Abingdon, United Kingdom

Stephen John Davies

USPTO Granted Patents = 15 

 

 

Average Co-Inventor Count = 4.0

ph-index = 6

Forward Citations = 104(Granted Patents)


Location History:

  • Oxfordshire, GB (2008)
  • Abingdon, GB (2010 - 2019)

Company Filing History:


Years Active: 2008-2019

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Stephen John Davies

Introduction

Stephen John Davies, an accomplished inventor based in Abingdon, GB, holds an impressive portfolio of 15 patents. His contributions to the pharmaceutical field demonstrate his dedication to innovation and the development of therapeutics aimed at addressing autoimmune and inflammatory diseases.

Latest Patents

One of Davies' most recent patents details a new compound named tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-YL]-3,5-difluorophenyl}ethyl]-L-alaninate. This compound, along with its salts, hydrates, or solvates, is designed to inhibit the activity of the p38 MAP kinase enzyme, making it potentially valuable in treating various autoimmune or inflammatory diseases and cell proliferative conditions. The invention also encompasses a pharmaceutical composition that incorporates the compound along with suitable carriers or excipients. Another key aspect of this invention is the acid resulting from the hydrolysis of the ester group of the compound, which is N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-YL]-3,5-difluorophenyl}ethyl]-L-alanine.

Career Highlights

Throughout his career, Stephen John Davies has worked with several leading companies in the pharmaceutical industry. Notable among these are Chroma Therapeutics Limited and Macrophage Pharma Limited. His extensive experience in drug development reflects his commitment to enhancing therapeutic solutions for pressing medical needs.

Collaborations

Stephen has collaborated with various professionals throughout his career, including notable colleagues David Festus Charles Moffat and Alan Hornsby Davidson. These collaborations have been instrumental in his innovative pursuits and the advancement of his research and development initiatives.

Conclusion

Stephen John Davies is a prominent figure in the realm of medical innovation, with a prolific track record of patents that underscore his contributions to pharmaceuticals. His work in developing compounds aimed at treating complex diseases highlights the critical nature of innovation in the medical field. As he continues to explore new horizons in drug development, his influence will likely resonate within the industry for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…